USP evaluates raw materials used in the chemical synthesis of peptides.
Michael Verlander
Advertisement
Michael Verlander is technical advisor at PolyPeptide Group.
Articles by Michael Verlander
USP evaluates quality attributes for synthetic peptides.
Advertisement
Latest Updated Articles
Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material ConsiderationsPublished: April 1st 2014 | Updated:
Control Strategies for Synthetic Therapeutic Peptide APIs— Part I: Analytical ConsiderationPublished: March 1st 2014 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Weekly News Roundup—Week of Oct. 13, 2025
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
4
Futureproofing Viral Safety: Global Perspectives from an Educator, Supplier, and Biosafety Expert
5
